Advertisement

World Journal of Pediatrics

, Volume 14, Issue 5, pp 498–503 | Cite as

Clinical features of postinfectious bronchiolitis obliterans in children undergoing long-term nebulization treatment

  • Xiao-Mei Zhang
  • Ai-Zhen Lu
  • Hao-Wei Yang
  • Li-Ling Qian
  • Li-Bo Wang
  • Xiao-Bo Zhang
Original Article
  • 42 Downloads

Abstract

Background

Limited data are available in relation to the clinical features of PIBO undergoing prolonged nebulization treatment with budesonide, terbutaline and ipratropium bromide. This retrospective study aimed to outline the features of clinical, high-resolution computed tomography (HRCT) and pulmonary function test (PFT) of PIBO, undergoing maintenance therapy utilizing a triple nebulization treatment and to determine the factors associated with prognosis.

Methods

Children diagnosed with PIBO were followed up between April 2014 and March 2017. The clinical features after maintenance nebulization treatment for 12 months were thereafter summarized.

Results

Thirty patients, 21 boys and 9 girls, were enrolled in the study. The median age of patients was 17.4 months, with a range between 3.0 and 33 months. Persistent coughing and wheezing were detected whilst wheezing and crackles were the common manifestations presented. HRCT scans revealed patchy ground and glass opacity, while PFT showed fixed airway obstruction in all patients. Four patients were lost during follow-up. After treatment, the clinical symptoms were improved greatly in all patients (P < 0.01). The mean increase in the percentage of TPEF%TE and VPEF%VE were improved greatly (P < 0.01). Images of the HRCT scan indicated marked improvements in 18 patients (81.8%) in comparison with scans obtained pre-treatment.

Conclusions

Our data suggest a potential role of long-term nebulization treatment of budesonide, terbutaline, ipratropium bromide on PIBO, due to its efficacy as indicated in the improved clinical symptoms, pulmonary functions and CT manifestations identified in the children. New prospective and controlled studies are required to confirm this proposition.

Keywords

Clinical features Nebulization treatment Post-infectious bronchiolitis obliterans Prognosis 

Notes

Author contributions

XMZ, AZL and HWY had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. XMZ, AZL, and XBZ. conceived and designed the study. XMZ and AZL reviewed the scientific literature, did the statistical analysis, prepared all tables and figures, and wrote the first draft of the report. LLQ, LBW and XBZ reviewed and revised the article. All authors made a critical revision of the manuscript for key intellectual content.

Funding

No financial or nonfinancial benefits have been received or will be received from any party related directly or indirectly to the subject of this article.

Compliance with ethical standards

Ethical approval

This study was approved by the Hospital’s Ethics Committee, and all participants provided written consents.

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Smith KJ, Fan LL. Insights into post-infectious bronchiolitis obliterans in children. Thorax. 2006;61:462–3.CrossRefPubMedCentralGoogle Scholar
  2. 2.
    Li YN, Liu L, Qiao HM, Cheng H, Cheng HJ. Post-infectious bronchiolitis obliterans in children: a review of 42 cases. BMC Pediatr. 2014;14:238.CrossRefPubMedCentralGoogle Scholar
  3. 3.
    Kim JS, Kim CK, Kim SW, Koh YY, Cohen AH, Deterding RR, White CW. Bronchiolitis obliterans in the 1990s in Korea and the United States. Chest. 2001;120:1101–6.CrossRefPubMedCentralGoogle Scholar
  4. 4.
    Aleman C, Alegre J, Recio J, Fernandez DST. Bronchiolitis obliterans organizing pneumonia associated with Legionella pneumophila. An Med Interna. 2002;19:133–5.PubMedPubMedCentralGoogle Scholar
  5. 5.
    Castro-Rodriguez JA, Daszenies C, Garcia M, Meyer R, Gonzales R. Adenovirus pneumonia in infants and factors for developing bronchiolitis obliterans: a 5-year follow-up. Pediatr Pulmonol. 2006;41:947–53.CrossRefPubMedCentralGoogle Scholar
  6. 6.
    Koh YY, Jung DE, Koh JY, Kim JY, Yoo Y, Kim CK. Bronchoalveolar cellularity and interleukin-8 levels in measles bronchiolitis obliterans. Chest. 2007;131:1454–60.CrossRefPubMedCentralGoogle Scholar
  7. 7.
    Chiu C, Wong K, Huang Y, Lin T. Bronchiolitis obliterans in children: clinical presentation, therapy and long-term follow-up. J Paediatr Child Health. 2008;44:129–33.CrossRefPubMedCentralGoogle Scholar
  8. 8.
    Murtagh P, Giubergia V, Viale D, Bauer G, Pena HG. Lower respiratory infections by adenovirus in children. Clinical features and risk factors for bronchiolitis obliterans and mortality. Pediatr Pulmonol. 2009;44:450–6.CrossRefPubMedCentralGoogle Scholar
  9. 9.
    Mauad T, Dolhnikoff M. Histology of childhood bronchiolitis obliterans. Pediatr Pulmonol. 2002;33:466–74.CrossRefPubMedCentralGoogle Scholar
  10. 10.
    Fischer GB, Sarria EE, Mattiello R, Mocelin HT, Castro-Rodriguez JA. Post infectious bronchiolitis obliterans in children. Paediatr Respir Rev. 2010;11:233–9.CrossRefPubMedCentralGoogle Scholar
  11. 11.
    Mattiello R, Sarria EE, Mallol J, Fischer GB, Mocelin H, Bello R, et al. Post-infectious bronchiolitis obliterans: can CT scan findings at early age anticipate lung function? Pediatr Pulmonol. 2010;45:315–9.CrossRefPubMedCentralGoogle Scholar
  12. 12.
    Colom AJ, Maffey A, Garcia Bournissen F, Teper A. Pulmonary function of a paediatric cohort of patients with postinfectious bronchiolitis obliterans. A long term follow-up. Thorax. 2015;70:169–74.PubMedPubMedCentralGoogle Scholar
  13. 13.
    Bosa VL, Mello ED, Mocelin HT, Benedetti FJ, Fischer GB. Assessment of nutritional status in children and adolescents with post-infectious bronchiolitis obliterans. J Pediatr. 2008;84:323–30.Google Scholar
  14. 14.
    Uyan ZS, Turan I, Ay P, Cakir E, Ozturk E, Gedik AH, et al. Sleep disordered breathing and sleep quality in children with bronchiolitis obliterans. Pediatr Pulmonol. 2016;51:308–15.CrossRefPubMedCentralGoogle Scholar
  15. 15.
    Cullinan P, Bush A. Growing old(er) with postinfectious bronchiolitis obliterans. Thorax. 2015;70:103–4.CrossRefPubMedCentralGoogle Scholar
  16. 16.
    Bashoura L, Gupta S, Jain A, Couriel DR, Komanduri KV, Eapen GA, et al. Inhaled corticosteroids stabilize constrictive bronchiolitis after hematopoietic stem cell transplantation. Bone Marrow Transpl. 2008;41:63–7.CrossRefGoogle Scholar
  17. 17.
    Kim SW, Rhee CK, Kim YJ, Lee S, Kim HJ, Lee JW. Therapeutic effect of budesonide/formoterol, montelukast and N-acetylcysteine for bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation. Respir Res. 2016;17:63.CrossRefPubMedCentralGoogle Scholar
  18. 18.
    Tomikawa SO, Adde FV, da Silva Filho LV, Leone C, Rodrigues JC. Follow-up on pediatric patients with bronchiolitis obliterans treated with corticosteroid pulse therapy. Orphanet J Rare Dis. 2014;9:128.CrossRefPubMedCentralGoogle Scholar
  19. 19.
    Lobo AL, Guardiano M, Nunes T, Azevedo I, Vaz LG. Post-infectious bronchiolitis obliterans in children. Rev Port Pneumol. 2007;13:495–509.CrossRefPubMedCentralGoogle Scholar
  20. 20.
    Calabrese C, Corcione N, Rea G, Stefanelli F, Meoli I, Vatrella A. Impact of long-term treatment with inhaled corticosteroids and bronchodilators on lung function in a patient with post-infectious bronchiolitis obliterans. J Bras Pneumol. 2016;42:228–31.CrossRefPubMedCentralGoogle Scholar
  21. 21.
    Xie BQ, Wang W, Zhang WQ, Guo XH, Yang MF, Wang L, et al. Ventilation/perfusion scintigraphy in children with post-infectious bronchiolitis obliterans: a pilot study. PLoS One. 2014;9:e98381.CrossRefPubMedCentralGoogle Scholar
  22. 22.
    Zhang L, Irion K, Kozakewich H, Reid L, Camargo JJ, da Silva Porto N, et al. Clinical course of postinfectious bronchiolitis obliterans. Pediatr Pulmonol. 2000;29:341–50.CrossRefPubMedCentralGoogle Scholar
  23. 23.
    Colom AJ, Teper AM, Vollmer WM, Diette GB. Risk factors for the development of bronchiolitis obliterans in children with bronchiolitis. Thorax. 2006;61:503–6.CrossRefPubMedCentralGoogle Scholar
  24. 24.
    Chan PW, Muridan R, Debruyne JA. Bronchiolitis obliterans in children: clinical profile and diagnosis. Respirology. 2000;5:369–75.CrossRefPubMedCentralGoogle Scholar
  25. 25.
    Colom AJ, Teper AM. Clinical prediction rule to diagnose post-infectious bronchiolitis obliterans in children. Pediatr Pulmonol. 2009;44:1065–9.CrossRefPubMedCentralGoogle Scholar
  26. 26.
    Wang X, Liu C, Wang M, Zhang YI, Li H, Liu G. Clinical features of post-infectious bronchiolitis obliterans in children undergoing long-term azithromycin treatment. Exp Ther Med. 2015;9:2379–83.CrossRefPubMedCentralGoogle Scholar
  27. 27.
    Rosewich M, Eckrich J, Zielen S. Long-term lung function in postinfectious bronchiolitis obliterans. Thorax. 2015;70:792.CrossRefPubMedCentralGoogle Scholar
  28. 28.
    Cazzato S, Poletti V, Bernardi F, Loroni L, Bertelli L, Colonna S, et al. Airway inflammation and lung function decline in childhood post-infectious bronchiolitis obliterans. Pediatr Pulmonol. 2008;43:381–390.CrossRefPubMedCentralGoogle Scholar
  29. 29.
    Rosewich M, Zissler UM, Kheiri T, Voss S, Eickmeier O, Schulze J, et al. Airway inflammation in children and adolescents with bronchiolitis obliterans. Cytokine. 2015;73:156–62.CrossRefPubMedCentralGoogle Scholar
  30. 30.
    Eckrich J, Herrmann E, Voss S, Schubert R, Zielen S, Rosewich M. Short-term variation of lung function and airway inflammation in children and adolescents with bronchiolitis obliterans. Lung. 2016;194:571–9.CrossRefPubMedCentralGoogle Scholar
  31. 31.
    Castro-Rodriguez JA, Giubergia V, Fischer GB, Castanos C, Sarria EE, Gonzalez R, et al. Postinfectious bronchiolitis obliterans in children: the South American contribution. Acta Paediatr. 2014;103:913–21.CrossRefPubMedCentralGoogle Scholar
  32. 32.
    Yu J. Postinfectious bronchiolitis obliterans in children: lessons from bronchiolitis obliterans after lung transplantation and hematopoietic stem cell transplantation. Korean J Pediatr. 2015;58:459.CrossRefPubMedCentralGoogle Scholar
  33. 33.
    Aguerre V, Castanos C, Pena HG, Grenoville M, Murtagh P. Postinfectious bronchiolitis obliterans in children: clinical and pulmonary function findings. Pediatr Pulmonol. 2010;45:1180–5.CrossRefPubMedCentralGoogle Scholar
  34. 34.
    Mosquera RA, Hashmi SS, Pacheco SE, Reverdin A, Chevallier J, Colasurdo GN. Dysanaptic growth of lung and airway in children with post-infectious bronchiolitis obliterans. Clin Respir J. 2014;8:63–71.CrossRefPubMedCentralGoogle Scholar

Copyright information

© Children's Hospital, Zhejiang University School of Medicine 2018

Authors and Affiliations

  • Xiao-Mei Zhang
    • 1
  • Ai-Zhen Lu
    • 1
  • Hao-Wei Yang
    • 2
  • Li-Ling Qian
    • 1
  • Li-Bo Wang
    • 1
  • Xiao-Bo Zhang
    • 1
  1. 1.Respiratory DepartmentChildren’s Hospital of Fudan UniversityShanghaiChina
  2. 2.Radiology DepartmentChildren’s Hospital of Fudan UniversityShanghaiChina

Personalised recommendations